Merck & Co., Inc. (6MK.F)
Develops and sells prescription medicines and vaccines for human and animal health worldwide
114.00-0.03%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+66.4%
The outlook
Merck is trading near the top of its 52-week range and above its key moving averages, reflecting steady upward momentum. The stock carries a trailing P/E of 36.5, which is elevated relative to historical pharma averages. Analyst sentiment leans constructive, though the valuation suggests limited margin for error.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range93% of the way from its 52-week low to high
Market cap
$281.56B
52-wk high
117.76
52-wk low
66.40
50-day avg
106.48
200-day avg
96.47
Trailing P/E
36.5